QUE Oncology
QUE Oncology develops novel therapies to address unmet medical needs in the treatment of cancer and its consequences.
Backed by
Uniseed
Brandon CapitalRaised 16M EQUITY on June 6, 2017
About
QUE Oncology is a clinical-stage biotechnology company developing investigational oncology therapies and conducting clinical trials to advance its cancer drug candidates.
Mission
QUE Oncology Inc. is described in the article as a clinical-stage biotechnology startup. The report notes that Australian venture capital firms Brandon Capital and Uniseed have invested in the company. Those investors committed up to $16 million to QUE Oncology. The article does not provide details on the company's specific product candidates, pipeline, or operating metrics. It also does not disclose the use of proceeds, valuation, or financing instrument for the investment.
Quick Facts
Founded
2012
Funding
EQUITY
Industry
Biopharma, Biotechnology, Health Care, Oncology, Therapeutics
Team Size
11-50
Headquarters
Melbourne, Victoria, Australia
Careers
View Careers Page
QUE Oncology
https://jobs.ashbyhq.com/queoncologyNo open roles at this time.
Check their careers page for updates